Visit SpeeDx at booth 103 to learn more about our PlexPCR and ResistancePlus solutions
SpeeDx specialises in providing innovative multiplex qPCR solutions for clinical diagnostics. SpeeDx’s portfolio of market leading detection and priming technologies enable new healthcare paradigms that lead to improved delivery and reduced costs. SpeeDx has a proven track record of scientific discovery and strives to provide cutting-edge and clinically-relevant tools to the Diagnostic market.
Learn more about our PlexPCRTM and ResistancePlusTM tests or Mycoplasma genitalium from booth 103 or any of the following events at ECCMID:
1. ePoster #EV0547 by Dr. Elisa Mokany: Multiplex detection of antibiotic resistance using new qPCR technology
2. Paper poster #P0930 by Dr. Sepehr Tabrizi: Multiplex assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance using PlexPCR
Date/time: 11 April 2016/12.30 – 13.30
3. Meet-the-Expert ECCMID conference session: How to diagnose and treat infections due toMycoplasma genitalium and other emerging sexually transmitted pathogens
Date/time: 11 April 2016/07.45 – 08.45
Look forward to seeing you there!
Follow us on @plexpcr for updates during the conference.